Market Value749,540,798
Total Holdings56
File Date2023-11-14
Original Filing (Click here)

All hedge funds or institutions that manage over $100M are required by the SEC to file quarterly reports on their holdings. These reports are called 13F reports. However, the filings are required the following quarter from the reporting period, which means that by the time the filing is made (and we see them), the information could be five months old.

For funds with long term positions that make few trades, the holdings might closely resemble their current holdings, even after several months. However, for funds that have high turnover, the holdings data we see might differ significantly from their current holdings. Institutions are required to report CALL and PUT options, and those positions are identified in the table. However, they are not required to report short positions.

Click the link icon to see the full transaction history.

Upgrade to unlock premium data and export to Excel .

Security Imputed
Share Price
Prev
Shares
Current
Shares
Change
(Percent)
Prev Value
(USD x1000)
Current Value
(USD x1000)
Change
(Percent)
SRPT / Sarepta Therapeutics, Inc.
TYRA / Tyra Biosciences, Inc.
DCTH / Delcath Systems, Inc.
IMUX / Immunic, Inc.
IMTX / Immatics N.V.
ACLX / Arcellx, Inc.
CMPS / COMPASS Pathways plc - Depositary Receipt (Common Stock)
IMVT / Immunovant, Inc.
RCKT / Rocket Pharmaceuticals, Inc.
RPTX / Repare Therapeutics Inc. Call
RCUS / Arcus Biosciences, Inc.
ICVX / Icosavax, Inc.
XENE / Xenon Pharmaceuticals Inc.
MOR / MorphoSys AG - Depositary Receipt (Common Stock)
VRDN / Viridian Therapeutics, Inc.
IMCR / Immunocore Holdings plc - Depositary Receipt (Common Stock)
RPTX / Repare Therapeutics Inc.
BIIB / Biogen Inc.
DBVT / DBV Technologies S.A. - Depositary Receipt (Common Stock)
ALLK / Allakos Inc.
COGT / Cogent Biosciences, Inc.
BCYC / Bicycle Therapeutics plc - Depositary Receipt (Common Stock)
NBIX / Neurocrine Biosciences, Inc.
AMAM / Ambrx Biopharma Inc.
CERE / Cerevel Therapeutics Holdings, Inc.
ETNB / 89bio, Inc.
GRCL / Gracell Biotechnologies Inc. - Depositary Receipt (Common Stock)
LIAN / LianBio - Depositary Receipt (Common Stock)
MRNS / Marinus Pharmaceuticals, Inc.
ZURA / Zura Bio Limited
MRTX / Mirati Therapeutics, Inc.
VERV / Verve Therapeutics, Inc.
KURA / Kura Oncology, Inc.
DAWN / Day One Biopharmaceuticals, Inc.
KRTX / Karuna Therapeutics, Inc.
SLNO / Soleno Therapeutics, Inc.
KALV / KalVista Pharmaceuticals, Inc.
VIGL / Vigil Neuroscience, Inc.
VTYX / Ventyx Biosciences, Inc.
NUVB.WS / Panacea Acquisition Corp. - Equity Warrant
SYRE / Spyre Therapeutics, Inc.
IOBT / IO Biotech, Inc.
MRSN / Mersana Therapeutics, Inc.
TNYA / Tenaya Therapeutics, Inc.
BMRN / BioMarin Pharmaceutical Inc.
AGLE / Aeglea BioTherapeutics Inc
VIR / Vir Biotechnology, Inc.
RYTM / Rhythm Pharmaceuticals, Inc.
ANNX / Annexon, Inc.
DSGN / Design Therapeutics, Inc.
ROIV / Roivant Sciences Ltd.
IOVA / Iovance Biotherapeutics, Inc. Call
BBIO / BridgeBio Pharma, Inc.
BBIO / BridgeBio Pharma, Inc. Call
LPTX / Leap Therapeutics, Inc.
GLPG / Galapagos NV - Depositary Receipt (Common Stock)
ACRS / Aclaris Therapeutics, Inc.
DYN / Dyne Therapeutics, Inc.
AKRO / Akero Therapeutics, Inc.
GPCR / Structure Therapeutics Inc. - Depositary Receipt (Common Stock)
ALXO / ALX Oncology Holdings Inc.
CRNX / Crinetics Pharmaceuticals, Inc.
ATXS / Astria Therapeutics, Inc.
GERN / Geron Corporation
IDYA / IDEAYA Biosciences, Inc.
OLMA / Olema Pharmaceuticals, Inc.
ELVN / Enliven Therapeutics, Inc.
APLS / Apellis Pharmaceuticals, Inc.
CYTK / Cytokinetics, Incorporated
MRUS / Merus N.V.
APLS / Apellis Pharmaceuticals, Inc. Call
RVMD / Revolution Medicines, Inc.